In order to maintain anabolic cancer metabolism, KRAS mutant pancreatic cancer rewires several metabolic pathways, and an understanding of how this metabolic reprogramming works can help offer some therapeutic interventions. This evidence concerns the gene KRAS and familial pancreatic carcinoma.